Literature DB >> 18239674

Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45.

R Rodriguez1, M E Gagou, M Meuth.   

Abstract

Checkpoint kinase 1 (Chk1) responds to disruption of DNA replication to maintain the integrity of stalled forks, promote homologous recombination-mediated repair of replication fork lesions, and control inappropriate firing of replication origins. This response is essential for viability as replication inhibitors trigger apoptosis in S-phase cells depleted of Chk1. Given the complex network of cellular responses controlled by Chk1, our aim was to determine which of these protect cells from apoptosis following replication stress. Work with cell-free systems has shown that RPA-ssDNA complex forms following replication inhibition through the uncoupling of replication and helicase complexes. Here we show that replication protein A (RPA) foci form in cells treated with replication inhibitors and that the number of foci dramatically increases together with hyperphosphorylation of RPA34 in Chk1-depleted cells in advance of the induction of apoptosis. RPA foci, RPA34 hyperphosphorylation, and apoptosis were suppressed by siRNA-mediated knockdown of Cdc45, an essential replication helicase cofactor required for both the initiation and elongation steps of DNA replication. In contrast, loss of p21, a negative effector of origin firing, stimulates both the accumulation of RPA foci and apoptosis. Taken together, these results suggest that the loss of control of replication origin firing following Chk1 depletion triggers the accumulation of the RPA-ssDNA complex and apoptosis when replication is blocked.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239674     DOI: 10.1038/cdd.2008.4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  19 in total

1.  Chk1 loss creates replication barriers that compromise cell survival independently of excess origin firing.

Authors:  Marina A González Besteiro; Nicolás L Calzetta; Sofía M Loureiro; Martín Habif; Rémy Bétous; Marie-Jeanne Pillaire; Antonio Maffia; Simone Sabbioneda; Jean-Sébastien Hoffmann; Vanesa Gottifredi
Journal:  EMBO J       Date:  2019-07-11       Impact factor: 11.598

2.  CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.

Authors:  Mitchell J Frederick; Jeffrey N Myers; Mayur A Gadhikar; Jiexin Zhang; Li Shen; Xiayu Rao; Jing Wang; Mei Zhao; Nene N Kalu; Faye M Johnson; Lauren A Byers; John Heymach; Walter N Hittelman; Durga Udayakumar; Raj K Pandita; Tej K Pandita; Curtis R Pickering; Abena B Redwood; Helen Piwnica-Worms; Katharina Schlacher
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

3.  Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors.

Authors:  W-T Wang; J W F Catto; M Meuth
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

4.  Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.

Authors:  Andrea Lunardi; Shohreh Varmeh; Ming Chen; Riccardo Taulli; Jlenia Guarnerio; Ugo Ala; Nina Seitzer; Tomoki Ishikawa; Brett S Carver; Robin M Hobbs; Valentina Quarantotti; Christopher Ng; Alice H Berger; Caterina Nardella; Laura Poliseno; Rodolfo Montironi; Mireia Castillo-Martin; Carlos Cordon-Cardo; Sabina Signoretti; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2015-02-04       Impact factor: 39.397

5.  High abundance of CDC45 inhibits cell proliferation through elevation of HSPA6.

Authors:  Yuanyuan Fu; Zhiyi Lv; Deqing Kong; Yuping Fan; Bo Dong
Journal:  Cell Prolif       Date:  2022-06-01       Impact factor: 8.755

6.  Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage.

Authors:  Béatrix Bugler; Estelle Schmitt; Bernadette Aressy; Bernard Ducommun
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

7.  Chk1 suppressed cell death.

Authors:  Mark Meuth
Journal:  Cell Div       Date:  2010-09-02       Impact factor: 5.130

8.  FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.

Authors:  Yun-Yong Park; Sung Yun Jung; Nicholas B Jennings; Cristian Rodriguez-Aguayo; Guang Peng; Se-Ran Lee; Sang Bae Kim; Kyounghyun Kim; Sun-Hee Leem; Shiaw-Yih Lin; Gabriel Lopez-Berestein; Anil K Sood; Ju-Seog Lee
Journal:  Carcinogenesis       Date:  2012-05-10       Impact factor: 4.944

9.  Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Manuel Masip; Purificación Catalina; Ana Nieto; Teresa de la Cueva; Mar Arriero; Nuria San Martin; Ernesto de la Cueva; Dimitrios Balomenos; Pablo Menendez; Javier García-Castro
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

10.  Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.

Authors:  Mary E Gagou; Pedro Zuazua-Villar; Mark Meuth
Journal:  Mol Biol Cell       Date:  2010-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.